GEN Exclusives

More »

The Lists

More »
Apr 2, 2013

Top 22 R&D Spenders among Tool and Technologies Companies

Find out how much money goes into developing the instruments you use for research.

Top 22 R&D Spenders among Tool and Technologies Companies

These tool and tech providers are investing the most in R&D among those in the biotechnology arena. [Natalia Merzlyakova - Fotolia.com]

  • A few weeks ago, GEN presented you with a list of the top 20 biopharma R&D spenders. However, drug discovery is only part of the R&D story; what about the companies that make the technology that makes drug discovery possible? Following is a list of top 25 life sciences tools and technologies providers—including both companies and divisions of broader corporate giants—as ranked by their R&D spending for 2012. Listings include R&D spending for 2012 and 2011, the percentage difference between the two years, the percentage of sales for both years, and 2008 R&D spending and percentage of sales.

  • #22. Fluidigm

    2012 R&D spending: $16.602 million

    2011 R&D spending: $13.936 million

    % Change: 19.1%

    2012 percentage of revenues: 31.7%

    2011 percentage of revenues: 32.5%

  • #21. Eppendorf International

    2012 R&D spending: $35.233 million (€27.5 million)1,2

    2011 R&D spending: $31.823 million (€24.838 million)2

    % Change: 10.7%

    2012 percentage of sales: 5.3%

    2011 percentage of sales: 5.2%

  • #20. Sartorius Stedim Biotech

    2012 R&D spending: $39.683 million (€30.972 million)3

    2011 R&D spending: $36.616 million (€28.580 million)3

    % Change: 8.4%

    2012 percentage of sales revenue: 5.7%

    2011 percentage of sales revenue: 6.0%

  • #19. Sequenom

    2012 R&D spending: $54.115 million

    2011 R&D spending: $53.585 million

    % Change: 1.0%

    2012 percentage of revenues: 60.3%

    2011 percentage of revenues: 95.8%

  • #18. Affymetrix

    2012 R&D spending: $57.881 million

    2011 R&D spending: $63.591 million

    % Change: -9.0%

    2012 percentage of revenues: 19.6%

    2011 percentage of revenues: 23.8%

  • #17. Sigma-Aldrich

    2012 R&D spending: $69 million

    2011 R&D spending: $72 million

    % Change: 4.2%

    2012 percentage of revenues: 2.6%

    2011 percentage of revenues: 2.9%

  • #16. Cepheid

    2012 R&D spending: $71.673 million

    2011 R&D spending: $59.362 million

    % Change: 20.7

    2012 percentage of revenues: 21.6%

    2011 percentage of revenues: 21.4%

  • #15. Waters

    2012 R&D spending: $96.004 million

    2011 R&D spending: $92.347 million

    % Change: 4.0%

    2012 percentage of net sales: 5.2%

    2011 percentage of net sales: 5.0%

  • #14. Mettler-Toledo International

    2012 R&D spending: $112.530 million

    2011 R&D spending: $116.139 million

    % Change: -3.1%

    2012 percentage of net sales: 4.8%

    2011 percentage of net sales: 5.0%

  • #13. Qiagen

    2012 R&D spending: $122.476 million

    2011 R&D spending: $130.636 million

    % Change: -6.2%

    2012 percentage of net sales: 9.8%

    2011 percentage of net sales: 11.2%

  • #12. PerkinElmer

    2012 R&D spending: $132.639 million

    2011 R&D spending: $115.821 million

    % Change: 14.5%

    2012 percentage of revenues: 6.3%

    2011 percentage of revenues: 6.0%


Add a comment

  • You must be signed in to perform this action.
    Click here to Login or Register for free.
    You will be taken back to your selected item after Login/Registration.

Related content

Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

Ebola Vaccines

When do you think an Ebola vaccine will be available for the general public?